Literature DB >> 9649995

Changes in plasma catecholamine concentrations and haemodynamic effects of rocuronium and vecuronium in elderly patients.

G D Shorten1, J Uppington, M E Comunale.   

Abstract

Rocuronium administration may cause tachycardia and an increase in cardiac index. Pancuronium, another steroidal non-depolarizing muscle relaxant, augments release of, and blocks re-uptake of catecholamines at adrenergic nerve endings. This study compared the haemodynamic effects of, and changes in catecholamine concentrations following administration of vecuronium (0.12 mg kg-1) or rocuronium (0.9 mg kg-1) to elderly patients. Thirty patients, 65 years or older, not receiving beta-blockers, were studied. During thiopentone, fentanyl, nitrous oxide anaesthesia, either rocuronium (0.9 mg kg-1) or vecuronium (0.12 mg kg-1) was administered, according to random allocation. In all 30 patients, blood pressure and heart rate were measured before induction of anaesthesia, immediately and 1 min after induction, 1 and 2 min after muscle relaxant administration, and immediately, 1 and 2 min after tracheal intubation. In the latter 20 patients, samples for plasma catecholamine estimation were obtained prior to, and 1 min after muscle relaxant administration and 1 min after tracheal intubation. Blood pressure and heart rate were similar in the two groups throughout the study. Plasma noradrenaline concentrations were similar in the vecuronium and rocuronium groups prior to muscle relaxant administration (589(SD240) and 444(SD213) pg mL-1, respectively), 1 min after muscle relaxant administration (602(SD220) and 520(SD392) pg mL-1, respectively) and 1 min after tracheal intubation (597(SD351) and 440(SD181) pg mL, respectively). There was no significant change in either plasma noradrenaline or adrenaline concentrations in either group following muscle relaxant administration or tracheal intubation. The use of rocuronium (0.9 mg kg-1) in elderly patients does not result in a clinically significant change in heart rate, blood pressure or plasma catecholamine concentration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649995     DOI: 10.1046/j.1365-2346.1998.00302.x

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  7 in total

1.  Investigation of the cardiac effects of pancuronium, rocuronium, vecuronium, and mivacurium on the isolated rat atrium.

Authors:  Sinan Gursoy; Ihsan Bagcivan; Nedim Durmus; Kenan Kaygusuz; Iclal Ozdemir Kol; Cevdet Duger; Sahin Yildirim; Caner Mimaroglu
Journal:  Curr Ther Res Clin Exp       Date:  2011-10

2.  General anaesthesia in elderly patients with cardiovascular disorders: choice of anaesthetic agent.

Authors:  Sangeeta Das; Kirsty Forrest; Simon Howell
Journal:  Drugs Aging       Date:  2010-04-01       Impact factor: 3.923

3.  Optimizing Reversal of Neuromuscular Block in Older Adults: Sugammadex or Neostigmine.

Authors:  Brandon M Togioka; Katie J Schenning
Journal:  Drugs Aging       Date:  2022-08-08       Impact factor: 4.271

Review 4.  Selecting neuromuscular-blocking drugs for elderly patients.

Authors:  Tristan M Cope; Jennifer M Hunter
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

5.  Comparison of intubating conditions between rocuronium with priming and without priming: Randomized and double-blind study.

Authors:  M Hanumantha Rao; Andal Venkatraman; R Mallleswari
Journal:  Indian J Anaesth       Date:  2011-09

6.  A comparative study of effect of sevoflurane on intubating conditions with rocuronium in neurosurgical patients.

Authors:  Saikat Mitra; Shobha Purohit; Sonali Bhatia; Poonam Kalra; Satya Prakash Sharma
Journal:  Indian J Anaesth       Date:  2015-12

7.  Comparison of injection pain in pediatric population; original versus generic rocuronium.

Authors:  Fumio Watanabe; Hiromi Kako; Mitsunori Miyazu
Journal:  Saudi J Anaesth       Date:  2020-01-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.